Eurofins Scientific SE (CHIX:ERFP) Ending Cash Position: €635 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ERFP Eurofins Scientific SE CHIX:ERFP
78 GF Score
Price €67.35
GF Value €66.58
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Eurofins Scientific SE Ending Cash Position?

Eurofins Scientific SE CHIX:ERFP -1.81% 78 Ending Cash Position is €635 Mil as of Jun. 2026. GuruFocus rates CHIX:ERFP with a GF Score™ of 78/100 and a GF Value™ of €66.58 (Fairly Valued). The stock has 4 warning signs investors should review.

Eurofins Scientific SE's Ending Cash Position for the quarter that ended in Jun. 2026 was €635 Mil.

Eurofins Scientific SE's quarterly Ending Cash Position increased from Jun. 2025 (€751 Mil) to Dec. 2025 (€788 Mil) but then declined from Dec. 2025 (€788 Mil) to Jun. 2026 (€635 Mil).

Eurofins Scientific SE's annual Ending Cash Position declined from Dec. 2023 (€1,221 Mil) to Dec. 2024 (€613 Mil) but then increased from Dec. 2024 (€613 Mil) to Dec. 2025 (€788 Mil).


Eurofins Scientific SE Ending Cash Position Related Terms


Eurofins Scientific SE Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Eurofins Scientific SE's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE Ending Cash Position Chart

Eurofins Scientific SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 515.00 483.20 1,220.90 613.20 787.80

Eurofins Scientific SE Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 680.60 613.20 751.10 787.80 635.00
CHIX:ERFP
78GF Score
Eurofins Scientific SE CHIX:ERFP
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurofins Scientific SE Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Eurofins Scientific SE's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=613.3+174.5
=788

Eurofins Scientific SE's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=787.7+-152.7
=635

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €635 Mil mean?
Eurofins Scientific SE (CHIX:ERFP) has a Ending Cash Position of €635 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Eurofins Scientific SE and its competitors.
Is Eurofins Scientific SE's Ending Cash Position too high?
Eurofins Scientific SE's current Ending Cash Position is €635 Mil. Overall, Eurofins Scientific SE has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Ending Cash Position compare to TMO and DHR?
Eurofins Scientific SE's Ending Cash Position of €635 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Diagnostics & Research company?
A good Ending Cash Position depends on the Medical Diagnostics & Research industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Eurofins Scientific SE and its competitors. Eurofins Scientific SE's current Ending Cash Position is €635 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (CHIX:ERFP) is currently considered Fairly Valued. The stock's GF Value™ is €66.58, compared to a current price of €67.35 — trading 1.2% above its estimated fair value. The current Ending Cash Position is €635 Mil. Eurofins Scientific SE's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Eurofins Scientific SE (CHIX:ERFP), the current Ending Cash Position is €635 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (CHIX:ERFP) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued. The current stock price of €67.35 is trading 1.2% above its estimated GF Value™ of €66.58. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for CHIX:ERFP:

  • Ending Cash Position: €635 Mil
  • GF Value™: €66.58 vs. price of €67.35 (1.2% above fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the CHIX:ERFP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
78GF Score

Get the complete analysis for CHIX:ERFP

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€67.35
Price
€66.58
GF Value